Will an oncologist of the not-so-distant future be able to pull up an image of a tumor biopsy slide on a screen and—without having to order a biomarker test—see the molecular characteristics of the cancer?
Rachelle Monteau first learned about Memorial Sloan Kettering Cancer Center through her father, who worked as a physician assistant, and who served on medical mission trips to Haiti, his home country.
Leonidas C. Platanias spoke with Alexandria Carolan, a reporter with The Cancer Letter:
Pamela Kunz said she left Stanford School of Medicine because of years of gender-related microaggressions and verbal abuse she experienced there.
The American Association of Cancer Research Sept. 16 published a comprehensive report on disparities in cancer, describing in deep detail the outsized toll that cancer exacts on racial and ethnic minorities and other underserved populations.
On Jan. 6, Barry P. Sleckman’s started his job as director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham.
NCI's publicly announced move to create an ad hoc working group that would review the feasibility and viability of the TMIST trial threatens to undercut this trial, said Mitchell Schnall, co-chair of ECOG-ACRIN Cancer Research Group, the group conducting the study.
In 1971, when the National Cancer Act was signed, Walter Lawrence, Jr., was one of the surgeons eager for a push forward, driven by rigorous science reviewed and funded by the federal government.
